Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pedersen, C, Breindahl, M, Aggarwal, N, Berglund, J, Oroszlán, G, Silfverdal, SA, Szüts, P, O'Mahony, M, David, M-P, Dobbelaere, K, Dubin, G & Descamps, D 2012, 'Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls', Journal of Adolescent Health, vol. 50, no. 1, pp. 38-46. https://doi.org/10.1016/j.jadohealth.2011.10.009

APA

Pedersen, C., Breindahl, M., Aggarwal, N., Berglund, J., Oroszlán, G., Silfverdal, S. A., Szüts, P., O'Mahony, M., David, M-P., Dobbelaere, K., Dubin, G., & Descamps, D. (2012). Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. Journal of Adolescent Health, 50(1), 38-46. https://doi.org/10.1016/j.jadohealth.2011.10.009

CBE

MLA

Vancouver

Author

Pedersen, Court ; Breindahl, Morten ; Aggarwal, Naresh ; Berglund, Johan ; Oroszlán, György ; Silfverdal, Sven Arne ; Szüts, Péter ; O'Mahony, Michael ; David, Marie-Pierre ; Dobbelaere, Kurt ; Dubin, Gary ; Descamps, Dominique. / Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. In: Journal of Adolescent Health. 2012 ; Vol. 50, No. 1. pp. 38-46.

Bibtex

@article{e172a9ddd32f447595948522fbd4a076,
title = "Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls",
abstract = "This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.",
author = "Court Pedersen and Morten Breindahl and Naresh Aggarwal and Johan Berglund and Gy{\"o}rgy Oroszl{\'a}n and Silfverdal, {Sven Arne} and P{\'e}ter Sz{\"u}ts and Michael O'Mahony and Marie-Pierre David and Kurt Dobbelaere and Gary Dubin and Dominique Descamps",
note = "Copyright {\textcopyright} 2012 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.jadohealth.2011.10.009",
language = "English",
volume = "50",
pages = "38--46",
journal = "Journal of Adolescent Health",
issn = "1054-139X",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

AU - Pedersen, Court

AU - Breindahl, Morten

AU - Aggarwal, Naresh

AU - Berglund, Johan

AU - Oroszlán, György

AU - Silfverdal, Sven Arne

AU - Szüts, Péter

AU - O'Mahony, Michael

AU - David, Marie-Pierre

AU - Dobbelaere, Kurt

AU - Dubin, Gary

AU - Descamps, Dominique

N1 - Copyright © 2012 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

PY - 2012

Y1 - 2012

N2 - This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.

AB - This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.

U2 - 10.1016/j.jadohealth.2011.10.009

DO - 10.1016/j.jadohealth.2011.10.009

M3 - Journal article

C2 - 22188832

VL - 50

SP - 38

EP - 46

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

IS - 1

ER -

ID: 33276592